Navigation Links
Arsenal Capital Partners Acquires Leading Model-Based Drug Development Company Certara
Date:12/19/2013

NEW YORK, Dec. 19, 2013 /PRNewswire/ -- Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market healthcare and specialty industrial companies, announced today the acquisition of Certara, the leading provider of model-based drug development and data analytics software and consulting services to the biopharmaceutical research and development market.Certara provides highly specialized and integrated solutions which consist of computer-based models supported by leading scientific consulting services and which span the discovery, pre-clinical and clinical stages of drug development. Certara's solutions provide clients with significant reductions in the time and expense of bringing new drugs to market by enabling data-driven decisions which lead to more precisely designed studies with less risk of failure and improved subject safety– a benefit in the highly-regulated and increasingly costly research and development environment.

Stephen McLean, a Partner at Arsenal and Co-Head of the firm's Healthcare Group, said, "We are delighted to invest in this exciting company which is making such an important contribution to improving the productivity of the drug development process. The average cost today of researching and developing a new drug is over $1.5 billion and takes 10-15 years. This is clearly inconsistent with the imperative of reducing the costs of global healthcare and Certara will make a difference."

Dr. James Rothman, a recipient of the 2013 Nobel Prize in Physiology or Medicine, who evaluated the Certara acquisition in his role in Arsenal Capital Partners' Healthcare Group, said Arsenal was interested in the acquisition because of Certara's ability to increase both the effectiveness and efficiency of the drug development process. "Model-based drug development is allowing pharmaceutic
'/>"/>

SOURCE Arsenal Capital Partners
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Soligenix Announces Initial $600,000 Investment and up to $10.6 Million Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC
2. UCLA Venture Capital Fund Selects KYTHERA Biopharmaceuticals CEO Keith Leonard for First Annual Entrepreneurial Achievement Award
3. TVM Capital Group Announces Two-pronged Global Investment Strategy with Renewed MENA Focus
4. Foundation Venture Capital Group Portfolio Company Identifies FRY Gene As Breast Cancer Susceptibility Suppressor
5. S&P Capital IQ to Share Its Views on the Biotech Bull Market During the Next "ETF Analyst Hour"
6. Relmada Therapeutics Inc. Completes $8.0 Million Capital Raise In Series A Financing
7. Regado Biosciences, Inc. to Present at Aegis Capital Vegas Healthcare Conference
8. GW Pharmaceuticals to Present at the 2013 Aegis Capital Healthcare Conference
9. Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)
10. RXi Pharmaceuticals Announces Application for NASDAQ Capital Market Listing and Reverse Stock Split
11. MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... YORK , April 21, 2015 AbilTo, ... today that its abstract submission has been accepted as ... Association,s (ADA) annual meeting taking place on June 5-6, 2015 ... According to the American Diabetes Association, the cost ... was $245 billion. As a result of increased inpatient, ...
(Date:4/21/2015)... April 21, 2015 Immune Pharmaceuticals Inc., or ... of Directors has elected Rene-Pierre Azria as ... Pricing Committee, with oversight on strategic and financial transactions. ... Audit Committee, the Compensation Committee and the Corporate Governance ... Azria commented: "I have a long-time interest in Life ...
(Date:4/21/2015)...  Novogen Limited (ASX:NRT; NASDAQ: NVGN ) ... it has entered into definitive agreements today to ... one attaching 6-month option and half of one ... to institutional investors in the United ... aggregate gross proceeds of approximately AU$15,500,000 ("Placement"). The ...
(Date:4/21/2015)... Thornton Cleveleys (UK) (PRWEB) April 21, 2015 ... PEEK* technology and its clinical applications will ... Meeting. Participants include engineers, scientists, regulators and ... worldwide. The meeting is sponsored by Invibio ... PEEK polymer-based biomaterials, a specialist in manufacturing ...
Breaking Biology Technology:AbilTo To Present at the 2015 American Diabetes Association Annual Meeting on Remote Delivery of Behavioral Change Therapy 2AbilTo To Present at the 2015 American Diabetes Association Annual Meeting on Remote Delivery of Behavioral Change Therapy 3Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 2Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 3Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 4Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 2Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 3Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 4Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 5Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 62nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 22nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 3
... like to be able to charge their cell phones ... A recent discovery made by UC San Diego engineers ... just this. In recent research, published in ... in the UCSD Department of Mechanical and Aerospace Engineering, ...
... Corporation (Nasdaq: OMER ) today announced unaudited financial results for ... ended September 30, 2009, Omeros reported a net loss of $3.9 ... of $7.4 million, or $2.54 per share, for the same period ... Company reported a net loss of $15.5 million, or $5.29 per ...
... , BETHESDA, Md., Nov. 19 Spherix Incorporated ... therapy, and a provider of technical and regulatory consulting services ... closed the previously reported $6.3 million registered direct placement to ... warrants to purchase up to 1,104,348 additional shares of its ...
Cached Biology Technology:Nanotube defects equal better energy and storage systems 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
(Date:4/1/2015)... April 1, 2015   Medisafe ™, the leading ... across iOS and Android smartphones ... biofeedback into the platform to allow patients to track ... the first time, patients will be able to visualize ... impacts important biometrics, such as glucose levels and blood ...
(Date:3/26/2015)... , March 26, 2015 ... family, social, recreation and athletic club, today announced it ... to allow freedom of movement for members and staff, ... "Following a comprehensive process, we selected FST,s IMID Access ... and convenience for our members and staff, in addition ...
(Date:3/24/2015)... 24, 2015   Crossmatch ™, a leading ... that its U.are.U ® 4500 Fingerprint Readers ... Bros . to achieve PCI compliance for Point-of-Sale ... to the POS terminal, protecting the retailer and ... breaches. With one-third of worldwide ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... David J. Friedman, MD, a clinician and scientific investigator ... Biology Research at Beth Israel Deaconess Medical Center (BIDMC) ... Award (CSDA) from the Doris Duke Charitable Foundation. The ... into the genetic and environmental factors that lead to ...
... genus and species of hadrosaur (duck-billed) dinosaur the ... been named by scientists who expect the discovery to ... feature of Acristavus gagslarsoni , the name given ... the distinctive ornamentation common to later duck-billed relatives. ...
... devices have become as common as the stethoscope in patient,s ... test results, access diagnostic tools and take patient notes, all ... or using a flash drive. These mobile devices are ideal ... security risks to patient information. In less than ...
Cached Biology News:BIDMC scientist David J. Friedman, M.D., receives award from Doris Duke Charitable Foundation 2New duck-billed dinosaur gives scientists clues to evolution of head ornamentation and provinciality 2Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth 2Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth 3Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth 4Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth 5
... degradation is critical to the maintenance ... regulatory proteins as important and diverse ... heat shock and stress response, antigen ... and ion channels, cell cycle regulation, ...
... Nucleic acid hybridization Preparation ... mg BSA, 50 mg ficoll ... with 5 ml of water ... for molecular biology Density: 1.00 ...
... The Vibratome Company has joined forces with ... the Vibratome 800 Tissue Chopper. This tissue ... sections of tissue for metabolic experiments and ... irregular specimens available at biopsy or from ...
... EvoQuest Custom Peptide Services offer a ... meet your research needs. Services include: ... Peptide synthesis, purified product ... modifications (acetylation, amidation, biotinylation, fluorescein, myristylation, phosphorylation, ...
Biology Products: